recombinant human interleukin-12 (Anhui Fengyuan Pharmaceutical)

N/A

Report date: 2025/03/20 10:02:00

Base Information

Drug Namerecombinant human interleukin-12 (Anhui Fengyuan Pharmaceutical)
Drug Alias Namerecombinant human interleukin-12 (University of Science and Technology of China)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterleukin-12 receptor stimulants
TargetsInterleukin-12 receptor
Therapy Area/IndicationsLung NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesUniversity Of Science And Technology Of China
China Registration ClassN/A

Develop Information

Active CompaniesAnhui Fengyuan Pharmaceutical Co Ltd
Inactive CompaniesUniversity Of Science And Technology Of China
Active IndicationsLung Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A